CRSP3
(Redirected from Intellectual disability, autosomal recessive 18)
Overview of CRSP3
CRSP3[edit | edit source]
CRSP3, also known as C1orf115, is a gene that encodes a protein involved in the transcriptional regulation of genes. This protein is a component of the Mediator complex, which is crucial for the transcription of nearly all RNA polymerase II-dependent genes. The Mediator complex serves as a bridge conveying information from gene-specific regulatory proteins to the basal transcription machinery.
Function[edit | edit source]
The CRSP3 protein is a subunit of the Mediator complex, which is a multi-protein complex that functions as a transcriptional coactivator in all eukaryotes. The Mediator complex is required for the transcription of nearly all class II gene promoters. It acts as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
CRSP3 specifically is involved in the regulation of gene expression by interacting with various transcription factors. It plays a role in the activation of transcription by facilitating the recruitment of the Mediator complex to gene promoters.
Structure[edit | edit source]
The CRSP3 protein is part of the larger Mediator complex, which is composed of multiple subunits. The exact structure of CRSP3 within the complex is not fully elucidated, but it is known to interact with other subunits to form a functional unit that can interact with transcription factors and RNA polymerase II.
Clinical significance[edit | edit source]
While specific diseases directly associated with mutations in CRSP3 have not been extensively documented, the Mediator complex, including CRSP3, is essential for normal cellular function. Disruptions in the function of the Mediator complex can lead to a variety of diseases, including certain types of cancer and developmental disorders.
Research[edit | edit source]
Ongoing research is focused on understanding the precise role of CRSP3 within the Mediator complex and its interactions with other proteins involved in transcriptional regulation. Studies are also exploring the potential implications of CRSP3 in various diseases, aiming to develop targeted therapies that can modulate its activity.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
